mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.00086 |
1 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.00071 |
1 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.00052 |
1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00021 |
1 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.00014 |
1 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.00011 |
1 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
6.6e-05 |
1 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-5.6e-05 |
1 |